EVH - Evolent Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD

29.14

+0.67

(+2.35%)

At close: 04:00PM EDT

29.69

+0.55

(+1.89%)

After hours:

05:09PM EDT

Stock chart is not supported by your current browser

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Double Moving Average Crossover

Performance Outlook

Short Term
2W - 6W
Mid Term
6W - 9M
Long Term
9M+

Previous Close	28.47
Open	28.47
Bid	27.71 x 800
Ask	28.54 x 800
Day's Range	28.29 - 29.25
52 Week Range	21.83 - 39.78
Volume	1,076,282
Avg. Volume	932,212

Market Cap	3.283B
Beta (5Y Monthly)	1.55
PE Ratio (TTM)	N/A
EPS (TTM)	-0.37
Earnings Date	Jul 31, 2023 - Aug 04, 2023
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	47.25

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for EVH

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

Simply Wall St.
Evolent Health, Inc.'s (NYSE:EVH) Intrinsic Value Is Potentially 76% Above Its Share Price
Key Insights Evolent Health's estimated fair value is US$57.93 based on 2 Stage Free Cash Flow to Equity Evolent Health...
PR Newswire
Evolent Health to Participate in Upcoming Conferences
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Chief Executive Officer Seth Blackley, Chief Financial Officer John Johnson and Vice President, Investor Relations Seth Frank will participate in upcoming investor conferences, including meetings with institutional investors and presentations.
Simply Wall St.
Market Still Lacking Some Conviction On Evolent Health, Inc. (NYSE:EVH)
With a median price-to-sales (or "P/S") ratio of close to 2.3x in the Healthcare Services industry in the United...
Thomson Reuters StreetEvents
Q1 2023 Evolent Health Inc Earnings Call
Q1 2023 Evolent Health Inc Earnings Call
Motley Fool
Evolent Health (EVH) Q1 2023 Earnings Call Transcript
Welcome to Evolent Health's earnings conference call for the quarter ended March 31st, 2023. Your host for the call today from Evolent Health are Seth Blackley, chief executive officer; and John Johnson, chief financial officer.
Zacks
Evolent Health (EVH) Beats Q1 Earnings Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of 40% and 1.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
PR Newswire
Evolent Health Announces First Quarter 2023 Results
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended March 31, 2023.
PR Newswire
Evolent Health Names New Independent Nominee for Election to Board of Directors
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced that a new director nominee will stand for election to the Board of Directors at the annual meeting of stockholders scheduled to be held on June 8, 2023.
Simply Wall St.
Evolent Health, Inc. (NYSE:EVH) Has Found A Path To Profitability
Evolent Health, Inc. ( NYSE:EVH ) is possibly approaching a major achievement in its business, so we would like to...
PR Newswire
Evolent Health to Release First Quarter Financial Results on Wednesday, May 3, 2023
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced it will release its first quarter 2023 financial results on Wednesday, May 3, 2023, after market close, with a conference call to follow at 5 p.m. ET.
Zacks
Centene (CNC) Expands Evolent Partnership to Boost Quality
Centene (CNC) expands the use of Evolent's oncology specialty care to improve cost management.
PR Newswire
Evolent Health and Centene Agree to Expanded Partnership for Oncology Specialty Care for Medicare Advantage Members
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers, today announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation, (NYSE: CNC).
Simply Wall St.
Investors in Evolent Health (NYSE:EVH) have made a massive return of 443% over the past three years
Evolent Health, Inc. ( NYSE:EVH ) shareholders might be concerned after seeing the share price drop 12% in the last...
Simply Wall St.
Evolent Health Full Year 2022 Earnings: EPS Misses Expectations
Evolent Health ( NYSE:EVH ) Full Year 2022 Results Key Financial Results Revenue: US$1.35b (up 49% from FY 2021). Net...
Benzinga
Evolent Health Q4 Top-Line Beats Expectation, Analyst Points To Visible Growth Outlook
Evolent Health Inc (NYSE: EVH) reported Q4 adjusted EPS of $0.10, missing the consensus of $0.16, compared to $0.08 a year ago. Revenues increased 54% Y/Y to $382.43 million, beating the consensus of $372.93 million. Total Lives on the Platform of 20.6 million as of Dec. 31, 2022, compared to 17.7 million a year ago. Total cases managed during the quarter within surgical management and advanced care planning totaled 15.7k, yielding an average per case revenue of $2.8k. Guidance: Evolent Health s
Motley Fool
Evolent Health (EVH) Q4 2022 Earnings Call Transcript
Welcome to Evolent Health's earnings conference call for the fourth quarter and year ended December 31, 2022. Your host for the call today from Evolent Health are Seth Blackley, chief executive officer; and John Johnson, chief financial officer.
Zacks
Evolent Health (EVH) Surpasses Q4 Earnings and Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of 66.67% and 2.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
PR Newswire
Evolent Health Announces Fourth Quarter and Full Year 2022 Results
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter ended December 31, 2022.
Zacks
EngageSmart (ESMT) Matches Q4 Earnings Estimates
EngageSmart (ESMT) delivered earnings and revenue surprises of 0% and 3.08%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insider Monkey
Here’s Why Evolent Health (EVH) Declined in Q4
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. Small-cap stocks posted solid returns in the fourth quarter for the first time in 2022. The Russell 2000 Growth Index was up 4.11% trailing the Russell 2000 […]
PR Newswire
Evolent Health, Inc. to Release Fourth Quarter Financial Results and Host Conference Call on Wednesday, February 22, 2023
Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its fourth quarter 2022 financial results on Wednesday, February 22, 2023 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.
American City Business Journals
Centene completes sale of benefit management subsidiary to Evolent Health
With the deal's close, Clayton-based health care giant Centene launches a multiyear partnership with Virginia-based Evolent Health.
Simply Wall St.
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Simply Wall St.
Is There Now An Opportunity In Evolent Health, Inc. (NYSE:EVH)?
While Evolent Health, Inc. ( NYSE:EVH ) might not be the most widely known stock at the moment, it received a lot of...
Simply Wall St.
Are Investors Undervaluing Evolent Health, Inc. (NYSE:EVH) By 48%?
Does the December share price for Evolent Health, Inc. ( NYSE:EVH ) reflect what it's really worth? Today, we will...